Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theriva Biologics Inc.

    AMEX: TOVX · Real-Time Price · USD
    0.49
    -0.02 (-3.54%)
    At close: Jul 24, 2025, 3:59 PM

    Theriva Biologics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 137K 135K 268K 87K
    Gross Profit
    		 n/a -135K -268K -87K
    Operating Income
    		 -26.35M -21.43M -21.58M -14.27M
    Interest Income
    		 697K 1.44M 512K 6K
    Pretax Income
    		 -25.65M -19.99M -21.11M -14.27M
    Net Income
    		 -25.65M -18.35M -19.68M -14.17M
    Selling & General & Admin
    		 7.4M 7.78M 9.86M 6.47M
    Research & Development
    		 12.03M 14.31M 11.72M 7.8M
    Other Expenses
    		 n/a -660K n/a n/a
    Operating Expenses
    		 19.43M 21.43M 21.58M 14.27M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 624K n/a n/a
    Cost & Expenses
    		 26.35M 21.43M 21.58M 14.27M
    Income Tax Expense
    		 n/a -1.64M -1.43M -94K
    Shares Outstanding (Basic)
    		 1.35M 644K 613.09K 12.19M
    Shares Outstanding (Diluted)
    		 1.35M 644.28K 613.09K 12.19M
    EPS (Basic)
    		 -19.03 -28.49 -32.11 -1.16
    EPS (Diluted)
    		 -19.03 -28.48 -32.11 -1.16
    EBITDA
    		 -26.35M -19.85M -21.58M -14.19M
    EBIT
    		 -25.65M -19.99M -21.11M -14.27M
    Depreciation & Amortization
    		 n/a 135K 268K 87K

    Add to Watchlist